NTRA.NASDAQNatera, INC

Form 4: Natera Legal Officer Exercises RSUs, Sells Shares for Tax

Sentiment:

Insider Transaction Report


Natera's SEC and Chief Legal Officer, Daniel Rabinowitz, acquired common stock through RSU vesting and subsequently sold a portion to cover tax obligations.

Summary

  • Daniel Rabinowitz, Natera, Inc.'s SEC and Chief Legal Officer, reported transactions involving the company's common stock.
  • On October 20, 2025, Rabinowitz acquired 856 shares of Natera Common Stock through the vesting of Restricted Stock Units (RSUs).
  • Following the RSU vesting, on October 21, 2025, Rabinowitz sold 464 shares of Common Stock at a price of $187.95 per share.
  • The sale of shares was executed to satisfy tax withholding and remittance obligations related to the RSU vesting.
  • This transaction was conducted under a Rule 10b5-1(c) plan, established on January 28, 2022, which provides an affirmative defense against insider trading allegations.
  • After these transactions, Rabinowitz's direct beneficial ownership of Natera Common Stock stands at 203,692 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a sale of shares, it's a routine, pre-planned event for tax purposes following RSU vesting, which itself is a positive for executive compensation and alignment. It does not indicate any negative sentiment from the insider regarding the company's future.

Positives

  • The vesting of 856 Restricted Stock Units (RSUs) indicates continued equity participation and alignment of the officer's interests with shareholders.
  • The transaction was conducted under a Rule 10b5-1(c) plan, demonstrating pre-planned and compliant insider trading practices.

Negatives

  • The sale of 464 shares, even for tax purposes, results in a reduction of the officer's direct beneficial ownership of Natera Common Stock.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceThe reported sale of shares was made pursuant to a written instruction intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. This demonstrates adherence to corporate governance best practices for insider transactions.January 28, 2022Enhances transparency and mitigates concerns regarding potential insider trading, aligning executive stock transactions with pre-established plans.

Stakeholder Impact

  • Shareholders: The transaction is a routine insider compensation event and tax-related sale, unlikely to have a significant direct impact on the broader shareholder base or stock price. It confirms executive equity alignment.
  • Employees: No direct impact mentioned.

Next Steps

  • Remaining Restricted Stock Units (RSUs) will continue to vest in 12 equal quarterly installments following January 20, 2023, as per the original vesting schedule.

Key Dates

DateDescription
January 28, 2022Date of the Reporting Person's Stock Unit Agreement grant, under which the Rule 10b5-1(c) plan was established.
January 20, 2023Date when 25% of the Restricted Stock Units (RSUs) vested.
October 20, 2025Date of RSU vesting and acquisition of 856 shares of Common Stock.
October 21, 2025Date of sale of 464 shares of Common Stock to satisfy tax obligations.
October 22, 2025Date the Statement of Changes in Beneficial Ownership (Form 4) was filed.

Recommendation

hold

This Form 4 filing details a routine insider transaction involving RSU vesting and a subsequent tax-related stock sale, executed under a Rule 10b5-1 plan. Such transactions are common and pre-scheduled, providing no new fundamental information about Natera's operational performance, strategic direction, or financial health. Therefore, it does not warrant a change in investment recommendation; a 'hold' stance is appropriate as the filing does not present new catalysts for significant price movement or a re-evaluation of the company's intrinsic value.

Keywords

Natera, NTRA, Form 4, Insider Transaction, Restricted Stock Unit, RSU, Stock Sale, Executive Compensation, Daniel Rabinowitz, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.